Evaluate the effect of Peganum Harmala on glycemic index in diabetic patient - Trial IRCT20170112031893N3
Access comprehensive clinical trial information for IRCT20170112031893N3 through Pure Global AI's free database. This Phase 3 trial is sponsored by Ghoum University of Medical Sciences and is currently Completed. The study focuses on Non-insulin-dependent diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT20170112031893N3
Phase 3
Completed
biological
Trial Details
Iranian Registry Of Clinical Trial • IRCT20170112031893N3
Evaluate the effect of Peganum Harmala on glycemic index in diabetic patient
Evaluate the effect of Peganum Harmala on glycemic index in diabetic patient, a triple-blind randomized, placebo controlled trial
Study Focus
Sponsor & Location
Ghoum University of Medical Sciences
Qom University of Medical Sciences
Iran
Timeline & Enrollment
Phase 3
Jan 21, 2019
N/A
ICD-10 Classifications
Other specified diabetes mellitus without complications
Unspecified diabetes mellitus without complications
Other specified diabetes mellitus
Other specified diabetes mellitus with other specified complications
Other specified diabetes mellitus with unspecified complications
Data Source
Iranian Registry Of Clinical Trial
IRCT20170112031893N3
Non-Device Trial